Sie sind auf Seite 1von 3

Aptitude Health Announces an Organizational Redesign to Better Deliver to Life

Sciences Companies the Oncology and Hematology Insights They Need Most

Transformation of business structure and leadership team; Axess Oncology and TRM Oncology
rebrand to Aptitude Health; All client accounts and services merge into one new operating
company; New solutions improve collaboration between life science partners and clinicians to
positively impact patient outcomes

Atlanta, GA, November 09, 2018 --(PR.com)-- Aptitude Health, a global provider of oncology insights
for the life sciences industry, announced today that the company will transform from a holding company
into an operating company. Effective immediately, its former businesses Axess Oncology and TRM
Oncology will rebrand to Aptitude Health. All client accounts and services will merge into Aptitude
Health.

As part of the restructuring of the new company, Aptitude Health's products and services will be
organized into 4 separate business units - business intelligence, promotional services, medical
publications, and medical communications.

At the core of the new Aptitude Health is the Axess Network of over 500 global scientific thought leaders
and more than 1,200 community physicians, making Aptitude Health the leading partner for organizations
that need actionable, up-to-the-minute insights on clinical decision-making in oncology and hematology.

“By rebranding into one business, we have created a single operating company to better serve the life
sciences industry,” said Alexei Rojanets, founder and CEO of Aptitude Health. “With our global portfolio
of products and unparalleled access to physicians, we are better positioned to deliver the insights and
evidence-based solutions our clients need for the clinical development and commercialization of existing
and future oncology products to positively impact patient outcomes.”

Aptitude Health's business intelligence products are designed to identify, understand, and respond to
dynamics that shape clinical decision-making in the oncology market. The company's promotional
services enable access to the right clinicians to provide on-label information and insights into how
therapies are best incorporated in patient care. The medical publications business unit facilitates the
development and dissemination of scientific insights that contribute to improved clinician knowledge, and
the company's medical communications enable the creation of the scientific content, insights, and
connections to make clinical innovations relevant and impactful.

Aptitude Health's leadership team

With these changes, the Aptitude Health Leadership Team includes:


· Alexei Rojanets, Founder and CEO
· Michael Fleming, Chief Commercial Officer
· Lee Lokey, MD, Chief Medical Officer
· Ross Schindler, Chief Marketing & Digital Officer

Page 1/3
PR.com Press Release Distribution Terms of Use
· Angela Coldwell, VP Finance
· Stefanie Daniels, Senior VP Global Strategic Business Development
· Kelley Hernandez, VP, US Strategic Business Development
· Eugene Vissers, MD, VP Scientific Content
· Sandra Mendes, PhD, CMPP, VP Medical Publications
· Kristof Petho, MD, VP Account Services

About Aptitude Health


Aptitude Health provides the world's leading life sciences companies with unparalleled physician access,
business intelligence, and medical communication solutions that translate clinical and commercial
successes into life-changing cancer treatments. Best-in-class products and services, combined with a
proven track record of success, make Aptitude Health the most valued partner for life sciences companies
seeking to identify, develop, and commercialize oncology and hematology innovations.

For more information, please visit www.aptitude-health.com

For media inquiries or information about this press release, please contact:
Emiel van Wegen
+31 70 30 67 200

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Aptitude Health
Emiel van Wegen
+31 70 30 67 200
Contact via Email
https://www.aptitude-health.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/769538

Page 3/3
PR.com Press Release Distribution Terms of Use

Das könnte Ihnen auch gefallen